MRKR
Marker Therapeutics Inc

4,992
Mkt Cap
$26.68M
Volume
1,499.00
52W High
$4.07
52W Low
$0.8099
PE Ratio
-1.30
MRKR Fundamentals
Price
$1.60
Prev Close
$1.61
Open
$1.66
50D MA
$1.53
Beta
1.15
Avg. Volume
283,731.45
EPS (Annual)
-$1.20
P/B
1.45
Rev/Employee
$1.32M
Loading...
Loading...
News
all
press releases
News Placeholder
MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know
Marker Therapeutics' shares jump 114% in three months as early MT-601 data showed strong responses, advanced into dose expansion, and lifted investor confidence.
Zacks·12d ago
News Placeholder
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics
Soleno Therapeutics leads a rebound in small drug stocks as innovation, pipeline progress and M&A activity fuel optimism for 2026.
Zacks·25d ago
News Placeholder
MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy?
Is it a good or bad thing when a stock experiences a golden cross technical event?
Zacks·26d ago
News Placeholder
5 Small Drug Stocks to Buy as Industry Recovery Picks Up
Innovation is at its peak in the Zacks Medical-Drugs industry. SLNO, NKTR, RIGL, IRWD and MRKR may prove to be good additions to one's portfolio.
Zacks·26d ago
<
...
1
>

Latest MRKR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.